Rosuvastatin increases myocardial microvessels in SHR rats. Role of thioredoxin-1 and peroxiredoxin-2 expression

International Journal of Cardiology

Volumn 174, Issue 1, 2014, Pages 153-155

  Cao, Gabriel ^a   Llambí, Hernán Gómez ^a   Muller, Angélica ^a   Ottaviano, Graciela ^a   Milei, José ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antioxidant effect; Heart; Rosuvastatin; Spontaneously hypertensive rat

Indexed keywords

AMINO ACID; PEROXIREDOXIN 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; ROSUVASTATIN; THIOREDOXIN 1; VASCULOTROPIN; FLUOROBENZENE; PEROXIREDOXIN; PYRIMIDINE DERIVATIVE; SULFONAMIDE; THIOREDOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY CAPILLARY DENSITY; CORONARY MICROVESSEL VOLUME DENSITY; HEART LEFT VENTRICLE MASS; HYPERTENSION; INTERSTITIUM VOLUME DENSITY; LETTER; LONG TERM CARE; MALE; MYOCARDIUM VOLUME DENSITY; MYOCYTE MEAN CROSS SECTIONAL AREA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; HEART; HEART VENTRICLE REMODELING; MICROVASCULATURE; PHYSIOLOGY;

ANIMALS; FLUOROBENZENES; HEART; MALE; MICROVESSELS; PEROXIREDOXINS; PYRIMIDINES; RATS; RATS, INBRED SHR; SULFONAMIDES; THIOREDOXINS; VENTRICULAR REMODELING;

EID: 84901200247     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.03.166     Document Type: Article

References (9)

1. C. Ott, M.P. Schneider, M.P. Schlaich, and R.E. Schmieder Rosuvastatin improves pulse wave reflection by restoring endothelial function Microvasc Res 84 1 2012 60 64
2. Z. Qiu, W. Zhang, and F. Fan et al. Rosuvastatin-attenuated heart failure in aged spontaneously hypertensive rats via PKCα/β2 signal pathway J Cell Mol Med 16 12 2012 3052 3061
3. T. Turoczi, V.W. Chang, and R.M. Engelman et al. Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1 J Mol Cell Cardiol 35 6 2003 695 704
4. G.L. Engelmann, J.C. Vitullo, and R.G. Gerrity Morphometric analysis of cardiac hypertrophy during development, maturation, and senescence in spontaneously hypertensive rats Circ Res 60 4 1987 487 494
5. S.G. Wu, Y.L. Chang, and J.W. Lin et al. Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction PLoS One 6 8 2011 e23303
6. C. Berndt, C.H. Lillig, and A. Holmgren Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system Am J Physiol Heart Circ Physiol 292 3 2007 H1227 H1236
7. S.G. Rhee, H.Z. Chae, and K. Kim Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling Free Radic Biol Med 38 12 15 2005 1543 1552
8. R. Mahalwar, and D. Khanna Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders Eur J Pharmacol 711 1-3 2013 57 62
9. R.S. Adluri, M. Thirunavukkarasu, and L. Zhan et al. Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice J Mol Cell Cardiol 50 1 2011 239 247